< Back to previous page
Project
Cardiovascular and muscle-specific "targeting" for gene therapy of neuromuscular disorders (FWOAL690)
Gene therapy is the use of DNA as a drug to treat disease by delivering therapeutic DNA into a patient's cells. In this project we will implement cardiovascular and muscle-specific "targeting" for gene therapy of neuromuscular disorders.
Date:1 Jan 2013 → 31 Dec 2016
Keywords:Fibrosis, Hepatic Stellate Cells, Histon (de)acetylation, Stellate cell activation, Liver Cell Transplantation, Liver Sinusoidal Cells, Portal hypertension, Sinusoidal Cells, cirrhosis, Cytoskeleton, Cell Biology, Fat-Storing Cells, NASH / NAFLD, Intermediate Filaments, liver stem / progenitor cells, autophagy, Flow Cytometry, Metabolic Syndrome
Disciplines:Gene and molecular therapy, Morphological sciences, Immunology, Molecular medicine, Oncology, Multimedia processing